Walleye Trading LLC Karyopharm Therapeutics Inc. Call Options Transaction History

Walleye Trading LLC

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2021 Feb 14, 2022	SELL	$5.21 - $8.61 $65,125 - $107,625	-12,500 Reduced 64.43%	6,900 $44,000
Q3 2021 Nov 15, 2021	SELL	$4.45 - $10.63 $3,115 - $7,441	-700 Reduced 3.48%	19,400 $113,000
Q2 2021 Aug 16, 2021	BUY	$8.11 - $11.11 $163,011 - $223,311	20,100 New	20,100 $207,000
Q4 2020 Feb 16, 2021	SELL	$14.15 - $17.19 $149,990 - $182,214	-10,600 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$14.14 - $19.71 $149,884 - $208,926	10,600 New	10,600 $155,000
Q2 2020 Aug 14, 2020	SELL	$16.6 - $25.25 $796,800 - $1.21 Million	-48,000 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$14.38 - $27.72 $690,240 - $1.33 Million	48,000 New	48,000 $922,000

57.6M

258K

81.2K

Ticker KPTI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 79,806,600
Market Cap $67M
Description
Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Trading LLC with notifications on news.